4-(4,4-Difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-yl)-butyric Acid

Collect

BASIC PARAMETERS Find an error

CAS: 878674-84-1
MF: C17H14BN2O2F2-.H+
MW: 328.121
Synonyms: 4-(4,4-Difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-yl)-butyric Acid

REPORT BY

Hong Wang

Wuhan University
follow

Robert E Sammelson

University of California
follow

Gregor Jung

Department of Biophysical Chemistry
follow
Co-reporter: Anh Minh Huynh;Andreas Müller;Sonja M. Kessler;Sarah Henrikus;Caroline Hoffmann;Alexra K. Kiemer;Arno Bücker;Gregor Jung
pp: 1568-1575
Publication Date(Web):
DOI: 10.1002/cmdc.201600120

Abstract

The combination of the two complementary imaging modalities 19F magnetic resonance imaging (MRI) and fluorescence imaging (FLI) possesses high potential for biological and medical applications. Herein we report the first design, synthesis, dual detection validation, and cytotoxic testing of four promising BODIPY dyes for dual 19F MRI–fluorescence detection. Using straightforward Steglich reactions, small fluorinated alcohols were easily covalently tethered to a BODIPY dye in high yields, leaving its fluorescence properties unaffected. The synthesized compounds were analyzed with various techniques to demonstrate their potential utility in dual imaging. As expected, the chemically and magnetically equivalent trifluoromethyl groups of the agents exhibited a single NMR signal. The determined longitudinal relaxation times T1 and the transverse relaxation times T2, both in the lower second range, enabled the imaging of four compounds in vitro. The most auspicious dual 19F MRI–fluorescence agent was also successfully imaged in a mouse post-mortem within a 9.4 T small-animal tomograph. Toxicological assays with human cells (primary HUVEC and HepG2 cell line) also indicated the possibility for animal testing.

Kirill Alexandrov

The University of Queensland
follow
Co-reporter: Dr. Debapratim Das;Zakir Tnimov;Dr. Uyen T. T. Nguyen;Dr. Govindaraju Thimmaiah;Dr. Harriet Lo;Dr. Daniel Abankwa;Dr. Yaowen Wu; Dr. Roger S. Goody; Dr. Herbert Waldmann; Dr. Kirill Alexrov
pp: 674-683
Publication Date(Web):
DOI: 10.1002/cbic.201100733

Abstract

Protein modification with isoprenoid lipids affects hundreds of signaling proteins in eukaryotic cells. Modification of isoprenoids with reporter groups is the main approach for the creation of probes for the analysis of protein prenylation in vitro and in vivo. Here, we describe a new strategy for the synthesis of functionalized phosphoisoprenoids that uses an aminederivatized isoprenoid scaffold as a starting point for the synthesis of functionalized phosphoisoprenoid libraries. This overcomes a long-standing problem in the field, where multistep synthesis had to be carried out for each individual isoprenoid analogue. The described approach enabled us to synthesize a range of new compounds, including two novel fluorescent isoprenoids that previously could not be generated by conventional means. The fluorescent probes that were developed using the described approach possess significant spectroscopic advantages to all previously generated fluorescent isoprenoid analogue. Using these analogues for flow cytometry and cell imaging, we analyzed the uptake of isoprenoids by mammalian cells and zebrafish embryos. Furthermore, we demonstrate that derivatization of the scaffold can be coupled in a one-pot reaction to enzymatic incorporation of the resulting isoprenoid group into proteins. This enables rapid evaluation of functional groups for compatibility with individual prenyltransferases and identification of the prenyltransferase specific substrates.